Study on the correlation between pathological classification of rheumatic mitral valve and surgical strategy in China
10.3760/cma.j.cn112434-20200303-00091
- VernacularTitle:中国风湿性二尖瓣病理三分型法与手术策略的相关性研究
- Author:
Tiange LUO
1
;
Xu MENG
Author Information
1. 首都医科大学附属北京安贞医院瓣膜及心脏移植中心 100029
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(10):579-584
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Based on past experience, to summarize a well-defined and applicable pathological classification scheme for rheumatic mitral valve disease from the point of view of the correlation with the selection of surgical methods.Methods:From January 2017 to January 2019, the cases undergoing mitral valve surgery due to rheumatic causes in our center were included. According to the degree of damage to the mitral valve leaflet, the damage to the junction, and the damage to the subvalvular structure in the junction, all the samples were divided into three pathological grades from mild to severe. The relevant clinical data of the included cases were summarized, the characteristics of each pathological grade and their correlation with surgical method were analyzed.Results:In two years, a total of 398 cases were included, of which 284 cases received rheumatic valvuloplasty, with an overall rate of 70%. Type Ⅰ was found in 58 cases, accounting for 15%, with plasty rate of 100%. Preoperative moderate-severe reflux accounted for 64%. Type Ⅱ was detected in 260 cases, accounting for 65%, with plasty rate of 76%(197/260). Preoperative moderate-severe stenosis accounted for 88%. In 80(20%) cases with type Ⅲ, the plasty rate was 36%(29/80), preoperative extremely severe stenosis accounted for 50% and preoperative moderate-severe reflux for 40%. In the cases receiving plasty, the mean MVOA and mean age decreased linearly with the increase in pathological grade. The proportions of preoperative LAAPD and E-wave, intraoperative aortic occlusion time and severe stenosis, mixed lesions and complete 4-step application increased linearly.Conclusion:Rheumatic mitral valvuloplasty has a huge room for improvement in China. Chinese Clinical Pathological Classification for Rheumatic Mitral Valve Disease provides a step-by-step route for the development of rheumatic mitral valvuloplasty.
